QVITI tES Regulatory Compliance Guidance

Warszawa, Poland

QVITI is a Polish neurotech/medtech company that has been developing technologies based on transcranial electrical stimulation (tES) and AI-enhanced immersive VR therapies since 2018. By leveraging the mechanisms of neuroplasticity, QVITI s solutions are applied not only in medical contexts but also in high-performance and high-stress environments , including the defense and security sectors , to enhance focus, cognitive resilience, recovery, and decision-making efficiency . In the medical field, QVITI s technologies bring measurable improvement to patients suffering from chronic pain, phantom pain, depression, and PTSD , while also accelerating neurological rehabilitation after stroke . The same neuroplasticity-driven mechanisms that support recovery can also be applied to neuro-enhancement —improving attention, stress resilience, training efficiency, and cognitive recovery in military and demanding operational settings. QVITI s solutions are already used across four continents , in clinics, research centers, and home therapy environments . The company collaborates with world-leading institutions such as Mount Sinai Hospital , Shirley Ryan AbilityLab , and Harvard Medical School , and its innovations are protected by an international patent portfolio . The flagship device, Corstim tES , provides safe, age-independent therapy for neurological rehabilitation, mental health support, and pain management .